Sargent Investment Group, LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 87 filers reported holding CYTOSORBENTS CORP in Q4 2018. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sargent Investment Group, LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$2,363,250
-49.0%
1,257,048
-2.5%
0.57%
-49.4%
Q2 2023$4,629,470
+9.6%
1,289,546
+5.8%
1.12%
+1.0%
Q1 2023$4,222,217
+176.8%
1,218,533
+23.8%
1.11%
+134.8%
Q4 2022$1,525,406
-24.8%
984,133
-11.2%
0.47%
-24.9%
Q3 2022$2,028,000
-5.3%
1,108,233
+13.4%
0.63%
-4.7%
Q2 2022$2,141,000
-18.9%
977,496
+18.1%
0.66%
-0.5%
Q1 2022$2,639,000
-19.7%
827,380
+5.4%
0.66%
-11.3%
Q4 2021$3,288,000
-58.0%
784,836
-18.6%
0.75%
-60.6%
Q3 2021$7,829,000
+21.1%
964,141
+12.6%
1.90%
+24.0%
Q2 2021$6,465,000
-5.0%
856,315
+9.2%
1.53%
-14.4%
Q1 2021$6,807,000
+26.8%
784,170
+16.4%
1.79%
+5.8%
Q4 2020$5,368,000
-2.8%
673,585
-2.8%
1.70%
-15.7%
Q3 2020$5,524,000
-20.8%
692,738
-1.0%
2.01%
-23.3%
Q2 2020$6,976,000
+91.3%
699,805
+48.3%
2.62%
+56.3%
Q1 2020$3,647,000
+89.8%
471,755
-5.5%
1.68%
+367.1%
Q4 2019$1,921,000
+29.1%
499,010
+68.6%
0.36%
-46.3%
Q3 2019$1,488,000
-32.6%
295,915
-11.4%
0.67%
-33.7%
Q2 2019$2,207,000
+1.2%
333,910
+15.9%
1.01%
-4.0%
Q1 2019$2,181,000
+8.2%
288,070
+15.5%
1.05%
-15.2%
Q4 2018$2,015,000249,4301.24%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 692,738$5,524,0002.01%
Skylands Capital, LLC 1,421,700$11,345,0001.89%
SECTORAL ASSET MANAGEMENT INC 1,629,989$12,999,0001.12%
Winning Points Advisors, LLC 286,200$1,142,990,0000.97%
Redmile Group, LLC 2,101,131$16,757,0000.31%
Granahan Investment Management 632,035$5,040,0000.17%
Avenir Corp 190,240$1,517,0000.16%
Seelaus Asset Management LLC 20,000$160,0000.13%
Olympiad Research LP 17,816$142,0000.07%
HighMark Wealth Management LLC 10,000$80,0000.07%
View complete list of CYTOSORBENTS CORP shareholders